Skip to main content
Clinical Trials/NCT02925026
NCT02925026CompletedNot Applicable

Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction

Washington University School of Medicine1 site in 1 country235 target enrollmentStarted: October 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
235
Locations
1
Primary Endpoint
Dual Sugar Absorption Test

Study Overview

Brief Summary

Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
12 Months to 35 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • children aged 12-35 months
  • youngest eligible child in each household

Exclusion Criteria

  • severe or moderate acute malnutrition
  • severe chronic illness
  • children unable to drink 20 mL of dual sugar solution
  • children in need of acute medical treatment for illness or injury at time of enrollment

Arms & Interventions

Placebo

Placebo Comparator

rice flour

Intervention: Placebo (Dietary Supplement)

Lactoferrin+Lysozyme

Experimental

lactoferrin and lysozyme in rice flour

Intervention: Lactoferrin (Dietary Supplement)

Lactoferrin+Lysozyme

Experimental

lactoferrin and lysozyme in rice flour

Intervention: Lysozyme (Dietary Supplement)

Outcomes

Primary Outcomes

Dual Sugar Absorption Test

Time Frame: 16 weeks

lactulose-mannitol ratio in urine

Secondary Outcomes

  • Lactulose Excretion(16 weeks)
  • Mannitol Excretion(16 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials